SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists

Aurora Cannabis Inc. (NASDAQ:ACB)

CA · Delayed Price · Currency is USD
4.29-0.06 (-1.38%)
 
Market Cap265.73M-21.9%
Revenue (ttm)290.25M-16.6%
Net Income-110.73M-514.1%
EPS-1.93-494.6%
Shares Out61.94M
PE Ration/a
Forward PE40.58
Dividendn/a
Ex-Dividend Daten/a
Volume624,107
Open4.25
Previous Close4.35
Day's Range4.24 - 4.34
52-Week Range2.56 - 6.36
Beta1.42
AnalystsHold
Price Target5.92(+38.00%)
Earnings DateNov 4, 2026
Insider Score
––Not scored
ACB Insider Score

No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.

About ACB

Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. Beyond its core product offerings, the company engages in a broad spectrum of related activities, including the design and engineering of facilities, cannabis breeding programs, research and development, and both wholesale and retail distribution channels. For medical users, Aurora provides a diverse selection of products such as different strains of dried cannabis, cannabis oils, capsules, and topical kits. Their inventory also includes ancillary items like vaporizers, vaporizer accessories, herb mills (specifically for CanniMed products), grinders, and secure containers for vaporizers. The company is actively involved in developing advanced medical cannabis products, with ongoing work on oral, topical, edible, and inhalable formulations. Furthermore, Aurora manages CanvasRX, a network of centers dedicated to cannabis counseling and community outreach. Its service portfolio extends to providing patient support, specialized design and construction services, and comprehensive analytical testing for cannabis products. Aurora Cannabis Inc. manages an extensive collection of brands, including Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. The company's main corporate office is located in Edmonton, Canada.

Address
90B Street SW, Edmonton, AB, T6X 1V8, CA
Market Cap
266 million
Employees
1,028
Industrial Classification
Drug Manufacturers - Specialty & Generic
1 Day
-1.38%
5 Days
-2.72%
1 Month
+12.60%
6 Months
+21.53%
1 Year
-21.86%

$ACB stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in ACB holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by ACB's directors and management

No SEC Form 4 activity for ACB in the last 5 quarters.

Source: SEC EDGAR (Form 4)

Corporate Lobbying

ACB Estimated quarterly lobbying spending

Source: U.S. Senate LDA

ACB Revenue by Segment or Geography

ACB's latest filing doesn't break out revenue by segment.

Source: SEC EDGAR (10-Q/10-K)

U.S. Patents

New ACB patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to ACB from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in ACB

ETFEst. Holding Size
VALTETFMG Sit Ultra Short ETF$6.65M
SILXETFMG Prime 2x Daily Junior Silver Miners ETF$6.46M
MJAmplify Alternative Harvest ETF$5.47M
YOLOAdvisorShares Pure Cannabis ETF$1.89M
THCXThe Cannabis ETF$903.24K
KPHOKraneshares Dragon Capital Vietnam Growth Index ETF$420.13K

Estimated from each fund’s disclosed top holdings × AUM

ACB Insider Score

Our composite score: insider buying, sector, volume, tone & dilution

No Insider Score for ACB yet — no open-market insider buys or sells in the last 90 days.

Bull Case vs Bear Case

AI-generated from ACB’s recent data — informational, not investment advice

Generating analysis…

Recent Insider Activity

No Form 4 filings in the last 90 days.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.